Search for: "State v. Lilly"
Results 341 - 360
of 910
Sort by Relevance
|
Sort by Date
10 Dec 2014, 9:50 am
See Vas-Cath Inc. v. [read post]
7 Dec 2014, 3:29 pm
Among the significant –- but, really, very-well indexed –- number of issues, the decision delves into novelty, inventive step, insufficiency by excessive claim breadth, added matter, and claim construction in light of the influential Actavis v Eli Lilly, another Arnoldian decision that the very same judge clarifies further in this ruling. [read post]
4 Dec 2014, 9:05 pm
If more editors handled situations this way, readers would think better of the press: Annalee Newitz of io9 offers “apology and analysis” for running tendentious, ill-reported article attacking animal-based research; Success of personal injury litigation is reshaping nursing home business in some states [WSJ] “With the Advent of Mandatory Paid Sick Leave in California, Here are a Few Sick Leave Excuses” [Coyote, related Massachusetts] Really, it’s not a… [read post]
2 Dec 2014, 7:35 am
The judge recorded:counsel pointed out that I had held in Actavis v Lilly at [112] that, in principle, a limitation made to a claim to avoid an objection of lack of clarity could be relied on as aid to construction. [read post]
21 Nov 2014, 11:22 am
The OFCCP states that the web-based portal for reporting and maintaining compensation information will be designed so that it “conforms with applicable government IT security standards. [read post]
13 Nov 2014, 11:26 am
The Pennsylvania case is Wisniewski v. [read post]
13 Nov 2014, 5:00 am
Eli Lilly & Co., ___ F. [read post]
7 Nov 2014, 5:52 am
Eli Lilly & Co., 394 F. [read post]
4 Nov 2014, 11:58 am
The notice states that “The Appellants wholly discontinues this Appeal on a without costs basis on consent. [read post]
19 Oct 2014, 5:27 am
Increasingly, the measures under scrutiny involve IP rights: Philip Morris currently challenges tobacco packaging rules in Australiaand Uruguayas a form of indirect expropriation; while the US pharmaceutical company Ely Lilly is suing Canadaunder NAFTA’s investment protection rules for the revocation of two crucial patents (for its drugs Zyprexa and Strattera) by Canadian courts.A confident Gustav pictured moments afterbeing asked to explain the internationalinvestment… [read post]
6 Oct 2014, 7:03 am
The Pennsylvania case is Wisniewski v. [read post]
24 Sep 2014, 4:54 am
Lilly v. [read post]
19 Sep 2014, 5:50 pm
Steven gave an example of the Canadian Federal Court case of Lilly Icos v Pfizer Ireland Pharmaceuticals (2006) FC 1465, where communications between Pfizer and a UK patent attorney was held not to be privileged. [read post]
25 Aug 2014, 8:57 am
Judge Koh, who was made globally famous when she presided in the Apple v Samsung dispute, stated that to do so would essentially be going overboard. [read post]
14 Aug 2014, 2:23 pm
Eli Lilly & Co., 744 F.2d 213, 216 (1st Cir. 1984), more appropriate. [read post]
10 Aug 2014, 7:52 pm
Ariad Pharm., Inc. v. [read post]
2 Aug 2014, 6:05 am
Niven v. [read post]
31 Jul 2014, 1:12 pm
Eli Lilly Co., 342 N.W.2d 37 (1984). [read post]
22 Jul 2014, 2:29 am
The SPC Blog carries a hot-off-the-press piece from victorious law firm Powell Gilbert following judgment in Eli Lilly v Human Genome Science. [read post]
21 Jul 2014, 10:32 am
”Even here, however, we see signs that UK courts are trying to be more consistent with the EPO, and in the HGS v Lilly litigation, reading the decision of the Supreme Court in Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 (see IPKat here) it is possible discern in the judgment a desire to not only apply the jurisprudence of the EPO Boards of Appeal, but also to reach the same conclusion (of sufficiency of the claims) on the specific… [read post]
